|
🐜
|
Mepolizumab and exacerbations of refractory eosinophilic asthma.
11 auth.
P. Haldar,
C. Brightling,
B. Hargadon,
S. Gupta,
W. Monteiro,
A. Sousa,
...
R. Marshall,
P. Bradding,
R. Green,
A. Wardlaw,
I. Pavord
|
9 |
2009 |
9
🐜
|
|
🐜
|
Rhinitis , sinusitis , and upper airway disease Mepolizumab , a humanized anti – IL-5 mAb , as a treatment option for severe nasal polyposis
11 auth.
P. Gevaert,
N. Bruaene,
T. Cattaert,
K. Steen,
T. Zele,
F. Acke,
...
N. D. Ruyck,
Katrien Blomme,
A. Sousa,
R. Marshall,
C. Bachert
|
8 |
2011 |
8
🐜
|
|
🐜
|
Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial
14 auth.
C. Bachert,
A. Sousa,
V. Lund,
G. Scadding,
P. Gevaert,
S. Nasser,
S. Durham,
M. Cornet,
H. Kariyawasam,
J. Gilbert,
...
D. Austin,
A. Maxwell,
R. Marshall,
W. Fokkens
|
8 |
2017 |
8
🐜
|
|
🦁
|
Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome.
9 auth.
R. Marshall,
S. Webb,
G. Bellingan,
H. Montgomery,
B. Chaudhari,
R. McAnulty,
...
S. Humphries,
M. Hill,
G. Laurent
|
8 |
2002 |
8
🦁
|
|
🐜
|
Common Promoter Variant in Cyclooxygenase-2 Represses Gene Expression: Evidence of Role in Acute-Phase Inflammatory Response
7 auth.
A. Papafili,
M. Hill,
D. Brull,
R. McAnulty,
R. Marshall,
S. Humphries,
...
G. Laurent
|
8 |
2002 |
8
🐜
|
|
🦁
|
Angiotensin II and the fibroproliferative response to acute lung injury.
8 auth.
R. Marshall,
P. Gohlke,
R. Chambers,
D. Howell,
S. Bottoms,
T. Unger,
...
R. McAnulty,
G. Laurent
|
8 |
2004 |
8
🦁
|
|
🐜
|
Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study.
17 auth.
R. Jenkins,
J. Simpson,
G. Saini,
J. Bentley,
A. Russell,
R. Braybrooke,
P. Molyneaux,
T. McKeever,
A. Wells,
A. Flynn,
...
R. Hubbard,
D. Leeming,
R. Marshall,
M. Karsdal,
P. Lukey,
Toby M. Maher,
Toby M. Maher
|
7 |
2015 |
7
🐜
|
|
🦁
|
Adult familial cryptogenic fibrosing alveolitis in the United Kingdom
R. Marshall,
Anna Puddicombe,
W. Cookson,
G. Laurent
|
7 |
2000 |
7
🦁
|
|
🦁
|
Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor.
R. Marshall,
R. McAnulty,
G. Laurent
|
7 |
2000 |
7
🦁
|
|
🐜
|
Elevated sputum interleukin-5 and submucosal eosinophilia in obese individuals with severe asthma.
21 auth.
D. Desai,
C. Newby,
F. Symon,
P. Haldar,
Sachil Shah,
S. Gupta,
M. Bafadhel,
A. Singapuri,
S. Siddiqui,
J. Woods,
...
A. Herath,
I. Anderson,
P. Bradding,
R. Green,
N. Kulkarni,
I. Pavord,
R. Marshall,
A. Sousa,
R. May,
A. Wardlaw,
C. Brightling
|
7 |
2013 |
7
🐜
|
|
🐬
|
Dissecting fibrosis: therapeutic insights from the small-molecule toolbox
C. Nanthakumar,
R. Hatley,
Seble Lemma,
J. Gauldie,
R. Marshall,
S. Macdonald
|
7 |
2015 |
7
🐬
|
|
🐜
|
Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF
18 auth.
P. Mercer,
Hannah V. Woodcock,
J. Eley,
M. Platé,
M. Sulikowski,
P. Durrenberger,
L. Franklin,
C. Nanthakumar,
Yim Man,
F. Genovese,
...
R. McAnulty,
Shuying Yang,
T. Maher,
A. Nicholson,
A. Blanchard,
R. Marshall,
P. Lukey,
R. Chambers
|
7 |
2016 |
7
🐜
|
